Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Elizabeth Anne Drury has worked on the following 10 EPO patent applications which have been published in the last five years:

EP12799114

METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES

IPC classification:
A61K 31/395, A61K 31/5375, A61P 27/02
Applicant:
Glaxo Group Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP12789372

NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

IPC classification:
A61K 31/17, A61P 3/00, A61P 17/00, A61P 31/00, C07C 275/42, C07D 213/75, C07D 217/24, C07D 237/20, C07D 239/42, C07D 241/20
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12789931

NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

IPC classification:
A61K 31/553, A61P 3/00, C07D 498/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13856479

NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

IPC classification:
A61K 31/553
Applicant:
GlaxoSmithKline LLC
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14723475

IMPROVED POXVIRAL VACCINES

IPC classification:
A61K 39/00, C07K 14/705
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14713598

PYRIDINE DERIVATIVES AS REARRANGED DURING TRANSFECTION (RET) KINASE INHIBITORS

IPC classification:
A61K 31/4412, A61P 1/06, C07D 213/69, C07D 401/12, C07D 413/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
PATENT GRANTED
EP15193141

NOVEL METHOD AND COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/015, A61K 39/12, A61K 39/21, A61K 39/35, C07K 14/005, C07K 14/16, C07K 14/35, C07K 14/445, C12N 15/861
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15766655

CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE

IPC classification:
A61K 31/4427, A61P 35/00, C07D 413/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
Request for examination was made
EP15840612

NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS

IPC classification:
A61K 31/4412, A61K 31/4427, A61P 1/00, A61P 35/00, A61P 43/00, C07D 211/94, C07D 217/24, C07D 239/22
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
Request for examination was made
EP15767599

PYRIDONE DERIVATIVES AS REARRANGED DURING TRANSFECTION (RET) KINASE INHIBITORS

IPC classification:
A61K 31/4412, A61P 35/00, C07D 213/69
Agent:
Elizabeth Anne Drury, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature